Apyx Medical Corp.

How big is Apyx Medical Corp.?

As of Jun 18, Apyx Medical Corp. has a market capitalization of 66.52 million, with net sales of 47.29 million and a net profit of -20.14 million over the last four quarters.

Market Cap: As of Jun 18, Apyx Medical Corp. has a market capitalization of 66.52 million, classifying it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Apyx Medical Corp. reported net sales of 47.29 million and a net profit of -20.14 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 14.21 million and total assets of 64.84 million.

What does Apyx Medical Corp. do?

Apyx Medical Corporation is a micro-cap company that designs and manufactures electrosurgical equipment in the Pharmaceuticals & Biotechnology industry. As of March 2025, it reported net sales of $9 million and a net loss of $4 million.

Overview:<BR>Apyx Medical Corporation is an energy-based medical device company engaged in the design, development, and manufacturing of electrosurgical equipment within the Pharmaceuticals & Biotechnology industry, categorized as a micro-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 9 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -4 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 66.52 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: 0.33 <BR>Return on Equity: -191.62% <BR>Price to Book: 6.33<BR><BR>Contact Details:<BR>Address: 5115 Ulmerton Rd, CLEARWATER FL: 33760-4004 <BR>Tel: 1 727 3842323 <BR>Website: https://apyxmedical.com/

Who are in the management team of Apyx Medical Corp.?

As of March 2022, the management team of Apyx Medical Corp. includes Andrew Makrides (Independent Chairman), Charles Goodwin (CEO), John Andres (Independent Vice Chairman), Lawrence Waldman (Lead Independent Director), and several Independent Directors: Minnie Baylor-Henry, Michael Geraghty, and Craig Swandal. They oversee the company's strategic direction and operations.

As of March 2022, the management team of Apyx Medical Corp. includes the following individuals:<BR><BR>- Mr. Andrew Makrides, Independent Chairman of the Board<BR>- Mr. Charles Goodwin, Chief Executive Officer and Director<BR>- Mr. John Andres, Independent Vice Chairman of the Board<BR>- Mr. Lawrence Waldman, Lead Independent Director<BR>- Ms. Minnie Baylor-Henry, Independent Director<BR>- Mr. Michael Geraghty, Independent Director<BR>- Mr. Craig Swandal, Independent Director<BR><BR>This team is responsible for overseeing the strategic direction and operations of the company.

Should I buy, sell or hold Apyx Medical Corp.?

Is Apyx Medical Corp. technically bullish or bearish?

As of August 19, 2025, Apyx Medical Corp. shows a mildly bullish trend with strong daily moving averages, though caution is advised due to mixed indicators, and it has significantly outperformed the S&P 500 over the past year but underperformed over three and five years.

As of 19 August 2025, the technical trend for Apyx Medical Corp. has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by daily moving averages indicating bullish momentum and weekly Bollinger Bands also signaling bullish conditions. However, the weekly MACD and KST are mildly bearish, and the monthly RSI is bearish, which suggests some caution. <BR><BR>In terms of performance, Apyx Medical Corp. has outperformed the S&P 500 significantly over the past year with a return of 113.33% compared to the S&P 500's 17.14%, but it has underperformed over the longer three and five-year periods.